SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-QT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-22-014834
Filing Date
2022-03-24
Accepted
2022-03-24 15:55:53
Documents
55
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 TRANSITION REPORT f10qt1221_bespoke.htm   iXBRL 10-QT 480213
2 CERTIFICATION f10qt1221ex31-1_bespoke.htm EX-31.1 12182
3 CERTIFICATION f10qt1221ex32-1_bespoke.htm EX-32.1 4309
  Complete submission text file 0001213900-22-014834.txt   3753579

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20211231.xsd EX-101.SCH 49252
5 XBRL CALCULATION FILE bspk-20211231_cal.xml EX-101.CAL 26600
6 XBRL DEFINITION FILE bspk-20211231_def.xml EX-101.DEF 241283
7 XBRL LABEL FILE bspk-20211231_lab.xml EX-101.LAB 450669
8 XBRL PRESENTATION FILE bspk-20211231_pre.xml EX-101.PRE 249690
49 EXTRACTED XBRL INSTANCE DOCUMENT f10qt1221_bespoke_htm.xml XML 284565
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-QT | Act: 34 | File No.: 000-52759 | Film No.: 22766426
SIC: 2834 Pharmaceutical Preparations